Patents by Inventor Esra Ogru

Esra Ogru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
    Patent number: 9168216
    Abstract: The invention relates to a carrier for administering biologically active compounds comprising one or more C1-C4 alcohols, polyols and polymers thereof, water and one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof. The carrier may be used in administering biologically active compounds, in particular pharmaceuticals including cosmetic agents.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: October 27, 2015
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventors: Paul Gavin, Robert Gianello, Esra Ogru
  • Alkaloid formulations
    Patent number: 8529947
    Abstract: There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: September 10, 2013
    Assignee: Vital Health Sciences Pty. Ltd.
    Inventors: Simon Michael West, Esra Ogru, Robert Gianello
  • COMPOUNDS HAVING ANTI-PROLIFERATIVE PROPERTIES
    Publication number: 20110003774
    Abstract: There is provided a method of inhibiting the occurrence of one of more of the following conditions:—the proliferation of monocytes/macrophages; or—the proliferation of smooth muscle cells; or—the expression of CD36 receptors; or—the uptake of oxidized LDL, the method comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: July 12, 2010
    Publication date: January 6, 2011
    Applicant: VITAL HEALTH SCIENCES PTY. LTD.
    Inventors: Simon Michael West, Esra Ogru
  • ALKALOID FORMULATIONS
    Publication number: 20100209459
    Abstract: There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: January 20, 2010
    Publication date: August 19, 2010
    Inventors: Simon Michael WEST, Esra OGRU, Robert GIANELLO
  • COMPOUNDS HAVING LIPID LOWERING PROPERTIES
    Publication number: 20090239827
    Abstract: There is provided a therapy for lowering the blood levels of a lipid selected from the group comprising LDL cholesterol, triglycerides, overall cholesterol and mixtures thereof, the therapy comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: January 6, 2006
    Publication date: September 24, 2009
    Inventors: Esra Ogru, Roksan Libinaki, Simon Michael West
  • COMPOUNDS HAVING ANTI-CANCER PROPERTIES
    Publication number: 20090233881
    Abstract: There is provided a method for alleviating symptoms, treating or preventing cancer, the method comprising administering to a subject, having or at risk of developing cancer, a pharmaceutical formulation comprising an effective amount of one or more phosphate derivatives of one or more hydroxy chromans selected from the group consisting of 7:8 dimethyl 6 hydroxy chromans, 8 methyl 6 hydroxy chromans and mixtures thereof.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 17, 2009
    Applicant: Vital Health Sciences Pty. Ltd
    Inventors: Simon Michael West, Esra Ogru, Robert Gianello
  • CARRIER COMPRISING ONE OR MORE DI AND/OR MONO-(ELECTRON TRANSFER AGENT) PHOSPHATE DERIVATIVES OR COMPLEXES THEREOF
    Publication number: 20090036354
    Abstract: The invention relates to a carrier for administering biologically active compounds comprising one or more C1-C4 alcohols, polyols and polymers thereof, water and one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof. The carrier may be used in administering biologically active compounds, in particular pharmaceuticals including cosmetic agents.
    Type: Application
    Filed: June 16, 2006
    Publication date: February 5, 2009
    Inventors: Paul Gavin, Robert Gianello, Esra Ogru
  • Compounds Having Cytokine Modulating Properties
    Publication number: 20090005348
    Abstract: A method of modulating one or more immuno-regulatory cytokines, such as pro-inflammatory and/or anti-inflammatory cytokines, comprising administering to a subject a therapeutically effective amount of one or more phosphate derivatives of one or more hydroxy chromans, or complexes thereof.
    Type: Application
    Filed: December 22, 2006
    Publication date: January 1, 2009
    Applicant: VITAL HEALTH SCIENCES PTY LTD
    Inventors: Esra Ogru, Roksan Libinaki, Robert Gianello
  • Carrier For Enternal Administration
    Publication number: 20090004166
    Abstract: There is provided a carrier for use in enteral administration of biologically active compounds, said carrier comprising an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: August 3, 2005
    Publication date: January 1, 2009
    Inventors: Simon Michael West, Esra Ogru
  • Alkaloid formulations
    Publication number: 20060281716
    Abstract: There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: March 3, 2005
    Publication date: December 14, 2006
    Inventors: Simon West, Esra Ogru, Robert Gianello
  • Compounds having anti-proliferative properties
    Publication number: 20060241085
    Abstract: There is a provided a method of inhibiting the occurrence of one of more of the following conditions: —the proliferation of monocytes/macrophages; or —the proliferation of smooth muscle cells; or —the expression of CD36 receptors; or —the uptake of oxidized LDL, the method comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: January 16, 2004
    Publication date: October 26, 2006
    Inventors: Simon West, Esra Ogru